Bilingual Telehealth Clinic Sol y Vida Launches Nationwide to Address Disparities in GLP-1 Access for Latino Patients
Found this article helpful?
Share it with your network and spread the knowledge!

A new bilingual telehealth clinic, Sol y Vida, launched nationwide today to address a stark disparity in access to advanced metabolic care for Latino patients. The Latino-founded clinic offers medical weight loss and metabolic care from licensed clinicians in both English and Spanish in all 50 states, opening as Hispanic Heritage Month begins on September 15.
The need is urgent. A 2024 national cohort study found that Hispanic patients are 47% less likely than White patients to be prescribed the newest GLP-1 medications, according to the clinic. Additionally, the National Hispanic Medical Association estimates that just 2% of eligible Latino patients access anti-obesity medications. Language barriers compound the problem: 68% of Hispanics and Latinos speak a language other than English at home, per HHS.
“We created Sol y Vida to provide another option — one where patients can communicate comfortably, understand their care and have meaningful conversations with licensed healthcare professionals in the language they prefer,” said founder Edgar Estrada.
The launch comes amid heightened scrutiny of telehealth marketing for compounded GLP-1 medications. The FDA has sent three waves of warning letters since late 2025 over such marketing. Sol y Vida takes a different approach: it is LegitScript-certified, publishes its program prices, and lists the claims it will not make. The clinic’s philosophy — “recetado, no comprado” (prescribed, not purchased) — is outlined on its website at https://solyvidaclinic.com/blog/por-que-recetado-no-comprado.
Care begins with a free 20-minute first consultation with no commitment. Licensed clinicians determine whether treatment is medically appropriate and prescribe accordingly. Programs include compounded semaglutide, dispensed by licensed compounding pharmacies. Compounded medications are not FDA-approved; the FDA does not review them for safety, effectiveness, or quality. Individual results vary.
For Texas, with its large and growing Hispanic population, the launch could signal improved access to care for a community that has historically faced barriers. The clinic’s bilingual model may also serve as a blueprint for other telehealth providers seeking to reach underserved populations. By offering transparent pricing and certification, Sol y Vida aims to build trust in a market where skepticism is high.
Sol y Vida Clinic is headquartered in Henderson, Nevada, and was founded in 2026. Its services are provided by licensed clinicians affiliated with independent medical practices in its network. More information is available at https://solyvidaclinic.com and LegitScript certification can be verified at https://legitscript.com.
